Home LiteratureArticle Details
PMID: 10551796 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Regulation of HIV-1 transcription.

Gene expression ·Vol. 8 ·No. 2 ·1999-00-00 ·Pages 67-84

Roebuck KA, Saifuddin M

Abstract

Human immunodeficiency virus type-1 (HIV-1) is a highly pathogenic lentivirus that requires transcription of its provirus genome for completion of the viral life cycle and the production of progeny virions. Since the first genetic analysis of HIV-1 in 1985, much has been learned about the transcriptional regulation of the HIV-1 genome in infected cells. It has been demonstrated that HIV-1 transcription depends on a varied and complex interaction of host cell transcription factors with the viral long terminal repeat (LTR) promoter. The regulatory elements within the LTR interact with constitutive and inducible transcription factors to direct the assembly of a stable transcription complex that stimulates multiple rounds of transcription by RNA polymerase II (RNAPII). However, the majority of these transcripts terminate prematurely in the absence of the virally encoded trans-activator protein Tat, which stimulates HIV-1 transcription elongation by interacting with a stem-loop RNA element (TAR) formed at the extreme 5' end of all viral transcripts. The Tat-TAR interaction recruits a cellular kinase into the initiation-elongation complex that alters the elongation properties of RNAPII during its transit through TAR. This review summarizes our current knowledge and understanding of the regulation of HIV-1 transcription in infected cells and highlights the important contributions human lentivirus gene regulation has made to our general understanding of the transcription process.

MeSH Terms
Base Sequence Chromatin/genetics,metabolism Gene Expression Regulation, Viral Genes, Regulator HIV-1/genetics,metabolism Humans Promoter Regions, Genetic Terminal Repeat Sequences Transcription Factors/biosynthesis,genetics
Chemicals
Chromatin Transcription Factors
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Roebuck K A
Department of Immunology/Microbiology, Rush Presbyterian St. Luke's Medical Center, Chicago, IL 60612, USA. [email protected]
Saifuddin M
References (207)
207 references, click to expand
  1. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.
    Science. 1997 Oct 31;278(5339):860-6 PMID: 9346484
  2. Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1.
    J Virol. 1992 Jun;66(6):3932-6 PMID: 1583736
  3. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat.
    J Biol Chem. 1995 Oct 27;270(43):25564-9 PMID: 7592727
  4. Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1.
    J Virol. 1996 Jul;70(7):4427-37 PMID: 8676466
  5. The transcriptional coactivators p300 and CBP are histone acetyltransferases.
    Cell. 1996 Nov 29;87(5):953-9 PMID: 8945521
  6. The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth.
    J Virol. 1997 Jul;71(7):5495-504 PMID: 9188623
  7. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat.
    J Virol. 1992 Jan;66(1):139-49 PMID: 1727476
  8. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
    J Immunol. 1998 Jul 1;161(1):268-76 PMID: 9647233
  9. Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens.
    J Immunol. 1989 Dec 15;143(12):3956-60 PMID: 2574206
  10. Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex.
    EMBO J. 1997 Sep 1;16(17):5260-72 PMID: 9311986
  11. The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes.
    Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):138-42 PMID: 8419915
  12. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation.
    EMBO J. 1993 Aug;12(8):3249-59 PMID: 8344262
  13. Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex.
    Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2505-10 PMID: 8637904
  14. Direct interaction of human TFIID with the HIV-1 transactivator tat.
    Nature. 1994 Jan 20;367(6460):295-9 PMID: 8121496
  15. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription.
    EMBO J. 1997 May 15;16(10):2836-50 PMID: 9184228
  16. A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation.
    Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):192-6 PMID: 8278363
  17. Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors.
    J Virol. 1995 May;69(5):3098-107 PMID: 7707538
  18. Transcription factors of the NFAT family: regulation and function.
    Annu Rev Immunol. 1997;15:707-47 PMID: 9143705
  19. Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression.
    J Virol. 1992 Sep;66(9):5594-7 PMID: 1501293
  20. Recruitment of human TBP selectively activates RNA polymerase II TATA-dependent promoters.
    J Biol Chem. 1998 Jun 26;273(26):16509-16 PMID: 9632719
  21. Repression of human immunodeficiency virus type 1 through the novel cooperation of human factors YY1 and LSF.
    J Virol. 1997 Dec;71(12):9375-82 PMID: 9371597
  22. Human immunodeficiency virus type 1 Tat-dependent activation of an arrested RNA polymerase II elongation complex.
    Virology. 1999 Mar 15;255(2):337-46 PMID: 10069959
  23. Histone acetyltransferases regulate HIV-1 enhancer activity in vitro.
    Genes Dev. 1997 Dec 15;11(24):3327-40 PMID: 9407026
  24. Promoter activity of Tat at steps subsequent to TATA-binding protein recruitment.
    Mol Cell Biol. 1997 Dec;17(12):6898-905 PMID: 9372921
  25. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation.
    J Virol. 1993 Jan;67(1):277-87 PMID: 8416373
  26. Tat-associated kinase (P-TEFb): a component of transcription preinitiation and elongation complexes.
    J Biol Chem. 1999 Mar 12;274(11):7399-404 PMID: 10066804
  27. Specific NF-kappa B subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription.
    J Virol. 1992 Jun;66(6):3883-7 PMID: 1583734
  28. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
    J Virol. 1994 Jan;68(1):103-10 PMID: 8254719
  29. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.
    EMBO J. 1993 Sep;12(9):3551-8 PMID: 8253080
  30. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.
    J Mol Biol. 1996 Sep 6;261(5):599-606 PMID: 8800208
  31. Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro.
    Genes Dev. 1992 May;6(5):761-74 PMID: 1577271
  32. Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II.
    Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11575-9 PMID: 8876177
  33. trans activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: a quantitative analysis.
    J Virol. 1989 Dec;63(12):5501-4 PMID: 2479775
  34. Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells.
    J Immunol. 1999 Feb 15;162(4):2427-31 PMID: 9973525
  35. Control of RNA initiation and elongation at the HIV-1 promoter.
    Annu Rev Biochem. 1994;63:717-43 PMID: 7979253
  36. HIV-1 core promoter lacks a simple initiator element but contains a bipartite activator at the transcription start site.
    J Biol Chem. 1993 Jul 25;268(21):15823-32 PMID: 8340407
  37. Involvement of TFIID and USA components in transcriptional activation of the human immunodeficiency virus promoter by NF-kappaB and Sp1.
    Mol Cell Biol. 1998 Jun;18(6):3234-44 PMID: 9584164
  38. The regulation of human immunodeficiency virus type-1 gene expression.
    Eur J Biochem. 1996 Sep 15;240(3):491-507 PMID: 8856047
  39. A unique thyroid hormone response element in the human immunodeficiency virus type 1 long terminal repeat that overlaps the Sp1 binding sites.
    J Biol Chem. 1995 Dec 29;270(52):31059-64 PMID: 8537364
  40. CREB regulates MHC class II expression in a CIITA-dependent manner.
    Immunity. 1999 Feb;10(2):143-51 PMID: 10072067
  41. Identification of a new serine kinase that activates NF kappa B by direct phosphorylation.
    J Biol Chem. 1993 Dec 15;268(35):26790-5 PMID: 8253816
  42. Extracellular human immunodeficiency virus type-1 Tat protein activates phosphatidylinositol 3-kinase in PC12 neuronal cells.
    J Biol Chem. 1996 Sep 20;271(38):22961-4 PMID: 8798481
  43. The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme.
    Mol Cell Biol. 1997 Apr;17(4):1817-23 PMID: 9121429
  44. Class II transactivator regulates the expression of multiple genes involved in antigen presentation.
    J Exp Med. 1995 Feb 1;181(2):765-7 PMID: 7836928
  45. NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1.
    Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7298-302 PMID: 8346247
  46. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer.
    EMBO J. 1999 Mar 1;18(5):1378-86 PMID: 10064603
  47. In vitro formation of short RNA polymerase II transcripts that terminate within the HIV-1 and HIV-2 promoter-proximal downstream regions.
    Genes Dev. 1989 Mar;3(3):265-82 PMID: 2542124
  48. Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors.
    J Biol Chem. 1996 Sep 13;271(37):22479-86 PMID: 8798413
  49. A novel LBP-1-mediated restriction of HIV-1 transcription at the level of elongation in vitro.
    J Biol Chem. 1995 Feb 3;270(5):2274-83 PMID: 7836461
  50. Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter.
    J Virol. 1995 Nov;69(11):6940-6 PMID: 7474112
  51. Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: involvement of NF-kappaB and NFAT.
    J Virol. 1998 Jun;72(6):4712-20 PMID: 9573235
  52. Mutations in the carboxy-terminal domain of TBP affect the synthesis of human immunodeficiency virus type 1 full-length and short transcripts similarly.
    J Virol. 1996 Aug;70(8):5025-34 PMID: 8764009
  53. Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-kappaB factors.
    J Immunol. 1998 Mar 15;160(6):2872-80 PMID: 9510190
  54. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors.
    Genes Dev. 1992 Apr;6(4):655-66 PMID: 1559613
  55. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B.
    EMBO J. 1991 Dec;10(12):3805-17 PMID: 1935902
  56. NF-kappa B-mediated activation of the human immunodeficiency virus enhancer: site of transcriptional initiation is independent of the TATA box.
    J Virol. 1989 Sep;63(9):4097-100 PMID: 2527315
  57. Distinct subdomains of human TAFII130 are required for interactions with glutamine-rich transcriptional activators.
    Mol Cell Biol. 1998 Oct;18(10):5734-43 PMID: 9742090
  58. Increased spacing between Sp1 and TATAA renders human immunodeficiency virus type 1 replication defective: implication for Tat function.
    J Virol. 1993 Dec;67(12):6937-44 PMID: 8230415
  59. Functional characterization of a complex protein-DNA-binding domain located within the human immunodeficiency virus type 1 long terminal repeat leader region.
    J Virol. 1989 Aug;63(8):3213-9 PMID: 2545899
  60. The binding of a Fos/Jun heterodimer can completely disrupt the structure of a nucleosome.
    EMBO J. 1997 Apr 15;16(8):2072-85 PMID: 9155033
  61. Cellular transcription factors involved in the regulation of HIV-1 gene expression.
    AIDS. 1992 Apr;6(4):347-63 PMID: 1616633
  62. The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat.
    J Virol. 1993 Apr;67(4):1752-60 PMID: 8445708
  63. The multifunctional role of the co-activator CBP in transcriptional regulation.
    Recent Prog Horm Res. 1997;52:103-19; discussion 119-20 PMID: 9238849
  64. Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat.
    Genes Dev. 1989 Apr;3(4):547-58 PMID: 2470647
  65. Nucleosomes and regulation of gene expression. Structure of the HIV-1 5'LTR.
    Acta Biochim Pol. 1998;45(1):209-19 PMID: 9701513
  66. Hematopoietic transcriptional regulation by the myeloid zinc finger gene, MZF-1.
    Curr Top Microbiol Immunol. 1996;211:159-64 PMID: 8585946
  67. Recruitment of the TATA-binding protein to the HIV-1 promoter is a limiting step for Tat transactivation.
    AIDS. 1998 Oct 22;12(15):1957-64 PMID: 9814863
  68. Sequence elements downstream of the human immunodeficiency virus type 1 long terminal repeat are required for efficient viral gene transcription.
    J Mol Biol. 1997 Sep 19;272(2):167-77 PMID: 9299345
  69. Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo.
    J Mol Biol. 1995 Jul 7;250(2):169-80 PMID: 7608968
  70. The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor.
    Genes Dev. 1998 Oct 1;12(19):2992-6 PMID: 9765201
  71. Interaction of human immunodeficiency virus type 1 Tat with a unique site of TFIID inhibits negative cofactor Dr1 and stabilizes the TFIID-TFIIA complex.
    J Virol. 1996 Aug;70(8):5503-10 PMID: 8764062
  72. Extracellular HIV-1 Tat protein induces a rapid and selective activation of protein kinase C (PKC)-alpha, and -epsilon and -zeta isoforms in PC12 cells.
    Biochem Biophys Res Commun. 1998 Jan 14;242(2):332-7 PMID: 9446795
  73. Exogenous human immunodeficiency virus type-1 Tat protein selectively stimulates a phosphatidylinositol-specific phospholipase C nuclear pathway in the Jurkat T cell line.
    Eur J Immunol. 1995 Sep;25(9):2695-700 PMID: 7589147
  74. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation.
    EMBO J. 1996 Mar 1;15(5):1112-20 PMID: 8605881
  75. Dual role of the nuclear factor of activated T cells insert region in DNA recognition and cooperative contacts to activator protein 1.
    Proc Natl Acad Sci U S A. 1997 May 13;94(10):4919-24 PMID: 9144165
  76. The role of chromatin in HIV-1 transcriptional regulation.
    Immunobiology. 1997 Dec;198(1-3):279-90 PMID: 9442399
  77. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function.
    EMBO J. 1993 Oct;12(10):3879-91 PMID: 8404856
  78. The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity.
    J Virol. 1989 Nov;63(11):4919-24 PMID: 2795721
  79. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes.
    J Virol. 1995 Sep;69(9):5337-44 PMID: 7636977
  80. The octamer-binding proteins Oct-1 and Oct-2 repress the HIV long terminal repeat promoter and its transactivation by Tat.
    Biochem J. 1997 Feb 15;322 ( Pt 1):155-8 PMID: 9078256
  81. Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity.
    J Virol. 1997 Aug;71(8):6113-27 PMID: 9223506
  82. Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages.
    J Exp Med. 1998 Apr 6;187(7):1103-11 PMID: 9529326
  83. Human immunodeficiency virus type 1 (HIV-1) infection and expression in intestinal epithelial cells: role of protein kinase A and C pathways in HIV-1 transcription.
    J Infect Dis. 1999 May;179 Suppl 3:S444-7 PMID: 10099116
  84. cis-acting sequences located downstream of the human immunodeficiency virus type 1 promoter affect its chromatin structure and transcriptional activity.
    Mol Cell Biol. 1996 Jun;16(6):2958-66 PMID: 8649407
  85. The NF-kappa B and I kappa B proteins: new discoveries and insights.
    Annu Rev Immunol. 1996;14:649-83 PMID: 8717528
  86. Characterization of the DNA-binding properties of the myeloid zinc finger protein MZF1: two independent DNA-binding domains recognize two DNA consensus sequences with a common G-rich core.
    Mol Cell Biol. 1994 Mar;14(3):1786-95 PMID: 8114711
  87. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1.
    Nucleic Acids Res. 1994 Nov 25;22(23):4914-21 PMID: 7800480
  88. Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages.
    J Infect Dis. 1991 Jan;163(1):78-82 PMID: 1984479
  89. Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and trans-activation.
    J Gen Virol. 1994 Aug;75 ( Pt 8):1927-34 PMID: 8046394
  90. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency.
    Immunity. 1995 May;2(5):545-53 PMID: 7749985
  91. Tat and the HIV-1 promoter.
    Curr Opin Cell Biol. 1993 Jun;5(3):461-8 PMID: 8352964
  92. Interactions of the transcription factor AP-1 with the long terminal repeat of different human immunodeficiency virus type 1 strains in Jurkat, glial, and neuronal cells.
    J Virol. 1995 Nov;69(11):6634-42 PMID: 7474072
  93. Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat.
    Science. 1996 Oct 25;274(5287):605-10 PMID: 8849451
  94. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells.
    J Virol. 1994 Jul;68(7):4177-85 PMID: 8207793
  95. Functional analysis of DNA bending and unwinding by the high mobility group domain of LEF-1.
    Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):12845-50 PMID: 9371763
  96. FBI-1, a factor that binds to the HIV-1 inducer of short transcripts (IST), is a POZ domain protein.
    Nucleic Acids Res. 1999 Mar 1;27(5):1251-62 PMID: 9973611
  97. Purified histone acetyltransferase complexes stimulate HIV-1 transcription from preassembled nucleosomal arrays.
    Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):12924-9 PMID: 9789016
  98. Distinct domains of IkappaB-alpha inhibit human immunodeficiency virus type 1 replication through NF-kappaB and Rev.
    J Virol. 1997 Apr;71(4):3161-7 PMID: 9060679
  99. Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1.
    J Biol Chem. 1996 Nov 1;271(44):27888-94 PMID: 8910388
  100. Stimulation of HIV type 1 gene expression and induction of NF-kappa B (p50/p65)-binding activity in tumor necrosis factor alpha-treated human fetal glial cells.
    AIDS Res Hum Retroviruses. 1994 Oct;10(10):1207-11 PMID: 7848678
  101. Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells.
    Eur J Immunol. 1997 Nov;27(11):2805-11 PMID: 9394803
  102. An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation.
    Mol Cell Biol. 1994 Oct;14(10):6570-83 PMID: 7935378
  103. Tat trans-activates the human immunodeficiency virus through a nascent RNA target.
    Cell. 1989 Oct 20;59(2):273-82 PMID: 2478293
  104. TNFalpha cooperates with the protein kinase A pathway to synergistically increase HIV-1 LTR transcription via downstream TRE-like cAMP response elements.
    Virology. 1997 Oct 27;237(2):422-9 PMID: 9356353
  105. Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction.
    Mol Cell Biol. 1993 Jul;13(7):3964-74 PMID: 8321203
  106. Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1.
    J Clin Invest. 1993 Sep;92(3):1336-48 PMID: 8376588
  107. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity.
    Proc Natl Acad Sci U S A. 1991 May 1;88(9):3720-4 PMID: 1827203
  108. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes.
    Mol Cell Biol. 1999 Jan;19(1):941-7 PMID: 9858618
  109. C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines.
    Immunity. 1996 Jul;5(1):91-101 PMID: 8758898
  110. A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter.
    J Virol. 1995 Dec;69(12):7437-44 PMID: 7494249
  111. The CBP co-activator is a histone acetyltransferase.
    Nature. 1996 Dec 19-26;384(6610):641-3 PMID: 8967953
  112. HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors.
    J Biol Chem. 1997 Jun 6;272(23):14883-92 PMID: 9169458
  113. DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1.
    J Virol. 1991 Dec;65(12):6790-9 PMID: 1942252
  114. Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts.
    Mol Cell Biol. 1997 Jul;17(7):3786-98 PMID: 9199312
  115. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.
    J Mol Biol. 1995 Dec 1;254(3):350-63 PMID: 7490754
  116. An NF-kappaB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kappaB-activating stimuli.
    J Biol Chem. 1996 Aug 23;271(34):20820-7 PMID: 8702837
  117. Genomic footprinting of HTLV type I and HIV type 1 in human T cell lines.
    AIDS Res Hum Retroviruses. 1996 Jun 10;12(9):829-32 PMID: 8738435
  118. Structural basis for DNA bending by the architectural transcription factor LEF-1.
    Nature. 1995 Aug 31;376(6543):791-5 PMID: 7651541
  119. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB.
    Nature. 1997 Aug 7;388(6642):548-54 PMID: 9252186
  120. U5 region of the human immunodeficiency virus type 1 long terminal repeat contains TRE-like cAMP-responsive elements that bind both AP-1 and CREB/ATF proteins.
    Virology. 1997 Jun 23;233(1):235-45 PMID: 9201233
  121. HIV type 1 extracellular Tat protein stimulates growth and protects cells of BK virus/tat transgenic mice from apoptosis.
    AIDS Res Hum Retroviruses. 1995 Sep;11(9):1039-48 PMID: 8554901
  122. Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat.
    Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7153-7 PMID: 7638159
  123. HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator.
    Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5281-6 PMID: 9560267
  124. Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro.
    Gene Expr. 1992;2(4):391-407 PMID: 1282057
  125. Upregulation of c-Fos in activated T lymphoid and monocytic cells by human immunodeficiency virus-1 Tat protein.
    Blood. 1997 Mar 1;89(5):1654-64 PMID: 9057648
  126. The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor.
    J Exp Med. 1999 Jan 4;189(1):51-62 PMID: 9874563
  127. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator.
    Mol Cell Biol. 1998 Nov;18(11):6777-83 PMID: 9774691
  128. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.
    EMBO J. 1998 Jul 1;17(13):3681-91 PMID: 9649438
  129. The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function.
    Genes Dev. 1991 Dec;5(12B):2496-507 PMID: 1752440
  130. An increase in p50/p65 NF-kB binding to the HIV-1 LTR is not sufficient to increase viral expression in the primary human astrocyte.
    Virology. 1994 Dec;205(2):586-90 PMID: 7975262
  131. Activation of the human immunodeficiency virus type 1 long terminal repeat by BTEB, a GC box-binding transcription factor.
    AIDS Res Hum Retroviruses. 1993 Sep;9(9):825-31 PMID: 8257632
  132. Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions.
    Genes Dev. 1995 Apr 15;9(8):995-1008 PMID: 7774816
  133. HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter.
    Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13519-24 PMID: 9811832
  134. In vitro chromatin assembly of the HIV-1 promoter. ATP-dependent polar repositioning of nucleosomes by Sp1 and NFkappaB.
    J Biol Chem. 1997 Jul 11;272(28):17654-61 PMID: 9211915
  135. The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32.
    Nucleic Acids Res. 1997 Jun 15;25(12):2522-8 PMID: 9171108
  136. HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1.
    J Immunol. 1998 Jul 15;161(2):776-81 PMID: 9670954
  137. TAFs mediate transcriptional activation and promoter selectivity.
    Trends Biochem Sci. 1996 Sep;21(9):338-42 PMID: 8870497
  138. Interleukin-10-induced HIV-1 expression is mediated by induction of both membrane-bound tumour necrosis factor (TNF)-alpha and TNF receptor type 1 in a promonocytic cell line.
    AIDS. 1996 Jul;10(8):835-42 PMID: 8828740
  139. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein.
    Genes Dev. 1998 Nov 15;12(22):3512-27 PMID: 9832504
  140. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.
    Proc Natl Acad Sci U S A. 1989 Aug;86(15):5974-8 PMID: 2762307
  141. Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat.
    J Virol. 1995 Oct;69(10):6572-6 PMID: 7666561
  142. CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells.
    Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8714-9 PMID: 9238043
  143. Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat.
    J Biol Chem. 1998 Sep 18;273(38):24898-905 PMID: 9733796
  144. Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production.
    J Virol. 1994 Feb;68(2):905-10 PMID: 8289393
  145. Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters.
    Genes Dev. 1988 Sep;2(9):1101-14 PMID: 2847959
  146. The relationship between tumor necrosis factor and human immunodeficiency virus gene expression in lymphoid tissue.
    J Virol. 1997 Sep;71(9):7080-2 PMID: 9261439
  147. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms.
    J Exp Med. 1990 Jul 1;172(1):151-8 PMID: 2193094
  148. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.
    Nature. 1987 Dec 3-9;330(6147):489-93 PMID: 2825027
  149. Activation domains of transcription factors mediate replication dependent transcription from a minimal HIV-1 promoter.
    Nucleic Acids Res. 1996 Feb 15;24(4):549-57 PMID: 8604293
  150. Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression.
    AIDS. 1996 Jul;10(8):819-26 PMID: 8828738
  151. Controlling elements in replication of the human immunodeficiency virus type 1.
    Cell Mol Biol (Noisy-le-grand). 1997 May;43(3):443-54 PMID: 9193800
  152. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).
    Cell. 1993 Oct 8;75(1):135-46 PMID: 8402893
  153. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain.
    Nature. 1996 Nov 28;384(6607):375-8 PMID: 8934526
  154. Repression of HIV-1 transcription by a cellular protein.
    Science. 1991 Mar 22;251(5000):1476-9 PMID: 2006421
  155. Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro.
    Genes Dev. 1995 Sep 1;9(17):2090-104 PMID: 7657162
  156. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
    Mol Med. 1995 Sep;1(6):667-77 PMID: 8529133
  157. Mycobacterium avium complex activates nuclear factor kappaB via induction of inflammatory cytokines.
    Cell Immunol. 1999 Feb 1;191(2):117-23 PMID: 9973533
  158. Identification of sequences downstream of the primer binding site that are important for efficient replication of human immunodeficiency virus type 1.
    J Virol. 1997 Aug;71(8):6003-10 PMID: 9223491
  159. Tat, Tat-associated kinase, and transcription.
    J Biomed Sci. 1998;5(1):24-7 PMID: 9570510
  160. Binding of NF-kB to the HIV-1 LTR is not sufficient to induce HIV-1 LTR activity.
    AIDS Res Hum Retroviruses. 1992 Feb;8(2):245-52 PMID: 1540410
  161. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.
    J Virol. 1998 Nov;72(11):8952-60 PMID: 9765440
  162. Protein-DNA interactions within DNase I-hypersensitive sites located downstream of the HIV-1 promoter.
    J Biol Chem. 1994 Aug 5;269(31):19916-24 PMID: 8051074
  163. Human immunodeficiency virus type-1 transcription: role of the 5'-untranslated leader region (review).
    Int J Mol Med. 1998 May;1(5):875-81 PMID: 9852310
  164. Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs.
    Mol Cell Biol. 1993 Feb;13(2):1251-63 PMID: 8423790
  165. Stable co-occupancy of transcription factors and histones at the HIV-1 enhancer.
    EMBO J. 1997 May 1;16(9):2463-72 PMID: 9171359
  166. Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat.
    J Virol. 1998 Apr;72(4):2615-29 PMID: 9525578
  167. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
    AIDS. 1997 Feb;11(2):139-46 PMID: 9030359
  168. Interaction of the COOH-terminal transactivation domain of p65 NF-kappa B with TATA-binding protein, transcription factor IIB, and coactivators.
    J Biol Chem. 1995 Mar 31;270(13):7219-26 PMID: 7706261
  169. CREB-binding protein/p300 are transcriptional coactivators of p65.
    Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):2927-32 PMID: 9096323
  170. Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.
    Science. 1986 May 9;232(4751):755-9 PMID: 3008338
  171. Molecular cloning and characterization of a novel TBP-1 interacting protein (TBPIP):enhancement of TBP-1 action on Tat by TBPIP.
    Biochem Biophys Res Commun. 1997 Oct 9;239(1):176-81 PMID: 9345291
  172. Extracellular HIV-1 Tat protein induces the rapid Ser133 phosphorylation and activation of CREB transcription factor in both Jurkat lymphoblastoid T cells and primary peripheral blood mononuclear cells.
    J Immunol. 1998 Apr 15;160(8):3891-8 PMID: 9558095
  173. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro.
    Genes Dev. 1997 Oct 15;11(20):2622-32 PMID: 9334325
  174. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.
    Science. 1987 Nov 6;238(4828):800-2 PMID: 3313729
  175. Molecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 Tat transactivator and encodes a strong transcriptional activation domain.
    J Virol. 1995 May;69(5):3007-16 PMID: 7707527
  176. Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter.
    Mol Cell Biol. 1998 May;18(5):2535-44 PMID: 9566873
  177. Exogenous tat protein activates human endothelial cells.
    Blood. 1993 Nov 1;82(9):2774-80 PMID: 7693046
  178. Characterization and purification of a novel transcriptional repressor from HeLa cell nuclear extracts recognizing the negative regulatory element region of human immunodeficiency virus-1 long terminal repeat.
    J Biol Chem. 1992 Dec 15;267(35):24948-52 PMID: 1459999
  179. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat.
    J Virol. 1998 Sep;72(9):7154-9 PMID: 9696809
  180. AP-1 function and regulation.
    Curr Opin Cell Biol. 1997 Apr;9(2):240-6 PMID: 9069263
  181. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
    J Mol Neurosci. 1994-1995;5(4):241-58 PMID: 7577367
  182. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA.
    Cell. 1998 Feb 20;92(4):451-62 PMID: 9491887
  183. Human immunodeficiency virus type 1 TAT protein activates B lymphocytes.
    Biochem Biophys Res Commun. 1997 Aug 18;237(2):461-4 PMID: 9268734
  184. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes.
    J Exp Med. 1994 Oct 1;180(4):1367-74 PMID: 7931070
  185. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor.
    J Virol. 1993 Oct;67(10):6224-33 PMID: 7690421
  186. Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein.
    EMBO J. 1993 Feb;12(2):479-87 PMID: 8382609
  187. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage.
    J Immunol. 1996 Jan 15;156(2):841-51 PMID: 8543841
  188. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription.
    J Mol Biol. 1995 May 5;248(3):562-80 PMID: 7752225
  189. In vitro activation of the HIV-1 enhancer in extracts from cells treated with a phorbol ester tumor promoter.
    EMBO J. 1987 Dec 20;6(13):4067-71 PMID: 3443102
  190. Tumor necrosis factor-alpha, interleukin 1, and phorbol myristate acetate are independent activators of NF-kappa B which differentially activate T cells.
    Cytokine. 1991 Sep;3(5):372-9 PMID: 1751774
  191. The HIV-1 TAT protein induces the expression and extracellular appearance of acidic fibroblast growth factor.
    J Biol Chem. 1995 Jul 21;270(29):17457-67 PMID: 7542239
  192. Transforming growth factor beta stimulates the human immunodeficiency virus 1 enhancer and requires NF-kappaB activity.
    Mol Cell Biol. 1998 Jan;18(1):110-21 PMID: 9418859
  193. Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes.
    J Virol. 1996 Mar;70(3):1384-9 PMID: 8627654
  194. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat.
    EMBO J. 1998 Dec 1;17(23):7056-65 PMID: 9843510
  195. Identification of cis-acting repressive sequences within the negative regulatory element of human immunodeficiency virus type 1.
    J Virol. 1990 Oct;64(10):5226-9 PMID: 2398545
  196. NF-kappa B homodimer binding within the HIV-1 initiator region and interactions with TFII-I.
    Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12376-81 PMID: 8901589
  197. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL.
    Nucleic Acids Res. 1998 Jan 1;26(1):362-7 PMID: 9399875
  198. NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro.
    Genes Dev. 1996 Jan 1;10(1):37-49 PMID: 8557193
  199. HSV-1 activation of HIV-1 transcription is augmented by a cellular protein that binds near the initiator element.
    Virology. 1993 Jan;192(1):370-4 PMID: 8390764
  200. The cAMP-dependent protein kinase A and protein kinase C-beta pathways synergistically interact to activate HIV-1 transcription in latently infected cells of monocyte/macrophage lineage.
    Virology. 1998 Jun 5;245(2):257-69 PMID: 9636365
  201. Regulation of HIV-1 gene expression by NF-IL6.
    J Mol Biol. 1996 Sep 27;262(3):327-35 PMID: 8844998
  202. Physical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells.
    J Virol. 1997 May;71(5):3563-73 PMID: 9094628
  203. Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITA.
    J Immunol. 1997 Aug 1;159(3):1086-95 PMID: 9233601
  204. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA).
    Immunity. 1995 May;2(5):533-43 PMID: 7749984
  205. Augmentation of human immunodeficiency virus type 1 gene expression by tumor necrosis factor alpha.
    AIDS Res Hum Retroviruses. 1989 Apr;5(2):131-8 PMID: 2713164
  206. Expanding the TRANSFAC database towards an expert system of regulatory molecular mechanisms.
    Nucleic Acids Res. 1999 Jan 1;27(1):318-22 PMID: 9847216
  207. Activation of the human immunodeficiency virus type 1 enhancer is not dependent on NFAT-1.
    J Virol. 1992 Jun;66(6):3961-5 PMID: 1533884
Article Info
Journal
Gene expression
Abbr.
Gene Expr
ISSN
1052-2166
Published
1999-00-00
Pages
67-84
Language
English
Region
United States
NLM ID
9200651
PMCID
PMC6157391
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]